HealthTech churn often comes down to whether the product fits real clinical and administrative workflows.
HealthTech SaaS — whether serving providers, payers, or patients directly — operates under unusually high stakes and unusually entrenched existing workflows. Churn here is frequently a workflow and adoption problem as much as a product problem, compounded by long buying cycles and multiple stakeholders who all need to stay bought in.
Where we typically find the leaks
- Low frontline adoption despite leadership buy-in. A product purchased at the administrative or executive level can still churn if the clinicians or staff actually using it day-to-day never fully adopt it.
- Integration and interoperability gaps. Products that don’t integrate cleanly with existing EHR/EMR systems or other core tools create ongoing friction that erodes usage over time.
- Compliance and security concerns. HIPAA and related regulatory requirements mean security or compliance gaps can trigger churn even when the core product experience is otherwise strong.
- Long, multi-stakeholder renewal cycles. With multiple decision-makers involved, renewal risk can build quietly across several relationships rather than showing up in a single clear signal.
What we help with
For HealthTech SaaS companies, we assess adoption gaps between purchasers and end users, evaluate how integration and compliance issues are affecting retention, and help build a renewal process that accounts for multiple stakeholders — rather than relying on a single champion relationship.